Evidence map›Paper›PMID 27605239›Full record

ArticleThe British journal of nutrition2016

Soluble transferrin receptor levels are positively associated with insulin resistance but not with the metabolic syndrome or its individual components.

Milton Fabian Suárez-Ortegón, Stela McLachlan, Sarah H Wild, José Manuel Fernández-Real, Caroline Hayward, Ozren Polašek

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Milton Fabian Suárez-Ortegón1Usher Institute of Population Health Sciences and Informatics,University of Edinburgh,Edinburgh EH8 9AG,UK.
Stela McLachlan1Usher Institute of Population Health Sciences and Informatics,University of Edinburgh,Edinburgh EH8 9AG,UK.
Sarah H Wild1Usher Institute of Population Health Sciences and Informatics,University of Edinburgh,Edinburgh EH8 9AG,UK.
José Manuel Fernández-Real3Department of Diabetes, Endocrinology and Nutrition,Institut d'Investigació Biomèdica de Girona (IdIBGi),CIBEROBN (CB06/03/010) and Instituto de Salud Carlos III (ISCIII),17007 Girona,Spain.
Caroline Hayward4Medical Research Council (MRC) Human Genetics Unit,Institute of Genetics and Molecular Medicine,University of Edinburgh,Western General Hospital,Edinburgh EH4 2XU,UK.
Ozren Polašek5Department of Public Health,School of Medicine,University of Split,21000 Split,Croatia.
University of Edinburgh · GBCentro de Investigación Biomédica en Red · ESMRC Institute of Genetics and Molecular Medicine · GBUniversidad del Valle · CO

Funding

Medical Research Council MC_PC_U127561128Wellcome Trust
6 · The paper itself

Abstract

The metabolic syndrome (MetS) is known to be associated with elevated serum ferritin levels. The possible association with other Fe markers has been less well studied. We aimed to investigate the cross-sectional association of soluble transferrin receptor (sTfR) and ferritin levels with the MetS components, insulin resistance and glycosylated Hb (HbA1C). The sample consisted of 725 adults, aged 19-93 years (284 men, 151 premenopausal and 290 postmenopausal women), from the Croatian island of Vis. Serum sTfR and ferritin levels were measured by immunoturbidimetry and electrochemiluminescence assays, respectively. The MetS was defined using modified international consensus criteria. Logistic and linear regression analyses were conducted to investigate the associations adjusting for age, fibrinogen, smoking status, alcohol consumption and BMI. Prevalence of the MetS was 48·7 %. Standardised values of ferritin were positively associated with all of the MetS components (except high blood pressure and waist circumference) in men (P0·05). sTfR levels could be spuriously elevated in subjects with insulin resistance and without association with the MetS or its components. We conclude that different markers of Fe metabolism are not consistently associated with cardiometabolic risk.

Indexed as

AdultAgedAged, 80 and overCroatiaFemaleFerritinsGlycated HemoglobinHumansHypertensionInsulin ResistanceMaleMetabolic SyndromeMiddle AgedPostmenopausePremenopauseReceptors, TransferrinFerritinsGlycated HemoglobinReceptors, TransferrinFerritinHbA1C glycosylated HbHFG high fasting glucoseHOMA-IR homoeostatic model assessment for insulin resistanceInsulin resistanceMetabolic syndromeMetS metabolic syndromeSoluble transferrin receptorsTfR soluble transferrin receptorWC waist circumference

Identifiers

PMID27605239
PMCPMC5860738
OpenAlexW2507907820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.